StonvexLoading…
StonvexStonvexStonvexCore line items from VRRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $223.57M | $979.08M | $721.22M | $459.28M |
Operating Income | $51.80M | $238.41M | $195.39M | $120.58M |
Net Income | $26.74M | $136.63M | $117.75M | $38.58M |
EPS (Diluted) | $0.17 | $0.85 | $0.73 | $0.44 |
Total Assets | $1.66B | $1.65B | $1.78B | $1.70B |
Total Liabilities | $1.38B | $1.35B | $1.38B | $1.34B |
Cash & Equivalents | $46.89M | $65.27M | $196.10M | $147.65M |
Free Cash Flow OCF − CapEx | $9.64M | $136.71M | $130.96M | $82.00M |
Shares Outstanding | 153.69M | 153.56M | 159.56M | 159.53M |